NCHR testimony at FDA about Clinical Trial Criteria for Interstitial Cystitis and Bladder Pain Syndrome

December 7, 2017. There is a need for new treatment options for interstitial cystitis and bladder pain syndrome (IC/BPS). These conditions have a range of causes and symptoms, and symptoms can be very similar to other conditions. This variation adds complexity to testing new treatments.  To meet the needs of patients, the FDA must hold the sponsors’ clinical trials to a high standard that ensures safe and effective treatments.

Read More »

NCHR Comments to HHS on Religious Exemptions and Contraceptives

December 5, 2017. We strongly oppose the IFR’s use of religious objections to undermine essential health care for millions of women in our country. The HHS must ensure the health of all our citizens by implementing policies based on sound medical and public health science. We urge that HHS bring evidenced-based practice into the forefront of health policies, as it has for decades.

Read More »

NCHR Comments on the USPSTF Draft Recommendations for Osteoporosis Screening

December 5, 2017. We strongly suggest the USPSTF provide a separate and clear “D” recommendation against screening in premenopausal women younger than 65. We strongly recommend that the USPSTF not finalize its recommendations until further information is made available regarding the direct benefits and harms of screening as noted above. In addition, we strongly urge that the evidence supports that the harms of drug therapies are “moderate” or “moderate to severe” and these risks be compared to the lack of evidence that these drugs reduce hip fractures, rather than concluding that the benefits are substantial and the risks are “no greater than small.” Last, we urge that USPSTF examine the benefits and harms of non-drug therapies as part of its screening recommendations.

Read More »

NCHR Comments on the USPSTF’s Evidence Review and Draft Recommendation Statement for Behavioral Counseling for Skin Cancer Prevention

November 6, 2017. We support USPSTF’s draft recommendations for behavioral counseling interventions to prevent skin cancer as well as their broader efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. As more information becomes available, we encourage the provision of additional recommendations about more specific behavioral interventions to prevent skin cancer for individuals in various subgroups.

Read More »
Page 1 of 5712345...102030...Last »